A carregar...
A 10-Year, Single Tertiary Care Center Experience on the Durability of Infliximab in Pediatric Inflammatory Bowel Disease
BACKGROUND: Despite increasing use of infliximab (IFX) in children with Crohn’s disease (CD) and ulcerative colitis (UC), long-term durability and safety of IFX beyond 1 year is limited in pediatric inflammatory bowel disease. METHODS: We performed a 10-year single-center retrospective cohort study...
Na minha lista:
| Publicado no: | Inflamm Bowel Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330671/ https://ncbi.nlm.nih.gov/pubmed/24552827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|